|
|
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1743-1751.
Prepublished online as a Blood First Edition Paper on October 24, 2006; DOI 10.1182/blood-2005-11-010504.
 Previous Article | Next Article 
Submitted November 15, 2005
Accepted August 29, 2006
SSEA-4 identifies mesenchymal stem cells from bone marrow
Eun J. Gang, Darko Bosnakovski, Camila A Figueiredo, Jan W Visser, and Rita CR Perlingeiro*
University of Texas Southwestern Medical Center
Viacell, Inc.
* Corresponding author; email: rita.perlingeiro{at}utsouthwestern.edu.
Adult bone marrow (BM) contains hematopoietic stem cells (HSCs) as well as a non-hematopoietic, stromal cell population. Within this stromal population are mesenchymal stem cells (MSCs), which not only support hematopoiesis, but also differentiate into multiple lineages, including fat, bone, and cartilage. Due to
this multipotentiality, the MSC is an attractive candidate for clinical applications to repair or regenerate damaged tissues of mesenchymal origin. However, research progress has been hampered by the limited existing knowledge of the biology of these cells, particularly by the lack of a suitable marker for their prospective isolation. Here we report that SSEA-4, an early embryonic glycolipid antigen commonly used as a marker for undifferentiated pluripotent human embryonic stem cells and cleavage to blastocyst stage embryos, also identifies the adult mesenchymal stem cell population.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Karystinou, F. Dell'Accio, T. B. A. Kurth, H. Wackerhage, I. M. Khan, C. W. Archer, E. A. Jones, T. A. Mitsiadis, and C. De Bari
Distinct mesenchymal progenitor cell subsets in the adult human synovium
Rheumatology,
September 1, 2009;
48(9):
1057 - 1064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. L. Battula, S. Treml, P. M. Bareiss, F. Gieseke, H. Roelofs, P. de Zwart, I. Muller, B. Schewe, T. Skutella, W. E. Fibbe, et al.
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1
Haematologica,
February 1, 2009;
94(2):
173 - 184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Haniffa, M. P. Collin, C. D. Buckley, and F. Dazzi
Mesenchymal stem cells: the fibroblasts' new clothes?
Haematologica,
February 1, 2009;
94(2):
258 - 263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Lee, M. J. Seo, A. A. Pulin, C. A. Gregory, J. Ylostalo, and D. J. Prockop
The CD34-like protein PODXL and {alpha}6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice
Blood,
January 22, 2009;
113(4):
816 - 826.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. Walkley, R. Qudsi, V. G. Sankaran, J. A. Perry, M. Gostissa, S. I. Roth, S. J. Rodda, E. Snay, P. Dunning, F. H. Fahey, et al.
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
Genes & Dev.,
June 15, 2008;
22(12):
1662 - 1676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Delorme, J. Ringe, N. Gallay, Y. Le Vern, D. Kerboeuf, C. Jorgensen, P. Rosset, L. Sensebe, P. Layrolle, T. Haupl, et al.
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells
Blood,
March 1, 2008;
111(5):
2631 - 2635.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Jones and D. McGonagle
Human bone marrow mesenchymal stem cells in vivo
Rheumatology,
February 1, 2008;
47(2):
126 - 131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Murphy, R. Summer, and A. Fine
Stem Cells in Airway Smooth Muscle: State of the Art
Proceedings of the ATS,
January 1, 2008;
5(1):
11 - 14.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
